These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7850836)

  • 21. Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up.
    Van Langenhove G; Vermeersch P; Serrano P; Kutryk MJ; Stockman D; Convens C; Van den Branden F; Vanagt E; Albertal M; Van den Heuvel P
    Can J Cardiol; 2000 Apr; 16(4):473-80. PubMed ID: 10787462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery.
    Niccoli G; Biscione C; Conte M; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial versus venous bypass grafts in patients with in-stent restenosis.
    Gaudino M; Cellini C; Pragliola C; Trani C; Burzotta F; Schiavoni G; Nasso G; Possati G
    Circulation; 2005 Aug; 112(9 Suppl):I265-9. PubMed ID: 16159829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approach to the patient with prior bypass surgery.
    Nguyen T; Pham L; Cheem TH; Douglas JS; Hermiller J; Grines C
    J Interv Cardiol; 2004 Oct; 17(5):339-46. PubMed ID: 15491339
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.
    Ellis SG; Kandzari D; Kereiakes DJ; Pichard A; Huber K; Resnic F; Yakubov S; Callahan K; Borgman M; Cohen SA
    J Invasive Cardiol; 2007 Oct; 19(10):404-9. PubMed ID: 17906340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saphenous vein graft disease.
    Peykar S; Angiolillo DJ; Bass TA; Costa MA
    Minerva Cardioangiol; 2004 Oct; 52(5):379-90. PubMed ID: 15514573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with stent implantation in the treatment of saphenous vein graft lesions.
    Wong SC; Popma JJ; Kent KM; Pichard AD; Satler LF; Mintz GS; Leon MB
    J Interv Cardiol; 1994 Dec; 7(6):565-73. PubMed ID: 10155205
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical experience with the Wiktor stent in native coronary arteries and coronary bypass grafts.
    Vaishnav S; Aziz S; Layton C
    Br Heart J; 1994 Sep; 72(3):288-93. PubMed ID: 7946784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous bailout therapy of a perforated vein graft using a stent-autologous vein patch.
    Colon PJ; Ramee SR; Mulingtapang R; Pridjian A; Bhatia D; Collins TJ
    Cathet Cardiovasc Diagn; 1996 Jun; 38(2):175-8. PubMed ID: 8776522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary stents.
    Porter J; Ahsan A; Mulcahy D; Sigwart U
    Br J Hosp Med; 1992 Mar 18-31; 47(6):411, 414, 417-9. PubMed ID: 1568081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restenosis after angioplasty.
    Cannon RO
    N Engl J Med; 2002 Apr; 346(16):1182-3. PubMed ID: 11961145
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergent saphenous vein graft stenting for acute occlusion during percutaneous transluminal coronary angioplasty.
    Mehl JK; Schieman G; Dittrich H; Buchbinder M
    Cathet Cardiovasc Diagn; 1990 Dec; 21(4):266-70. PubMed ID: 2276201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of balloon rupture during rigid stent deployment.
    Keelan ET; Nunez BD; Berger PB; Holmes DR; Garratt KN
    Cathet Cardiovasc Diagn; 1995 Jul; 35(3):211-5. PubMed ID: 7553825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current status of intracoronary stent: an overview.
    Lau KW; Sigwart U
    Singapore Med J; 1992 Apr; 33(2):143-9. PubMed ID: 1621117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stents for intracoronary placement: current status and future directions.
    Eeckhout E; Kappenberger L; Goy JL
    J Am Coll Cardiol; 1996 Mar; 27(4):757-65. PubMed ID: 8613600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathology of new interventional procedures in coronary disease.
    Waller BF
    Cardiovasc Clin; 1988; 18(2):63-122. PubMed ID: 2958133
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicenter evaluation of the Strecker tantalum stent for acute coronary occlusion after angioplasty.
    Hamm CW; Beythien C; Sievert H; Langer A; Utech A; Terres W; Reifart N
    Am Heart J; 1995 Mar; 129(3):423-9. PubMed ID: 7872165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic observations in coronary arteries, aortocoronary saphenous vein bypass grafts and infant aortae following balloon angioplasty procedures.
    Waller BF
    Herz; 1985 Oct; 10(5):255-68. PubMed ID: 2933310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.